Subscribe to RoboticOncology.com RSS Feed

Reducing Prostate Cancer Deaths

Dr. David Samadi, top robotic prostatectomy surgeon, redirects prostate cancer emphasis to treatment decisions following diagnosis.


NEW YORK, Jan. 20, 2012 /PRNewswire/ -- The annual PSA debate wages on in 2012 as further data challenging the effectiveness of routine prostate cancer screening and its impact on prostate cancer deaths is published. The Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO), the same group upon which the United States Preventative Services Task Force based their 2011 anti-PSA recommendations, maintains their claim that the Prostate-Specific Antigen (PSA) test does not reduce prostate cancer deaths.

Early this month the PLCO re-published their research in The Journal of the National Cancer Institute. The new report extended the follow-up period by six years, for a total of 13 years; however, the same conclusion was reached – widespread, routine prostate cancer screenings do not reduce prostate cancer deaths. The study is flawed by the fact that approximately 50% of the control group was actually screened with PSA at some point during the review period. "This study is really looking at the difference between routine PSA screening and intermittent screening. It is not a clean comparison of PSA testing verses non-PSA testing," reasons Dr. Samadi.

Studies out of Europe, which did show a reduced mortality benefit with PSA screening, had much lower levels of PSA screening in their control groups. One study out of Sweden, for example, found a 20 percent reduction in mortality after 14 years of follow-up.  

As Vice Chairman, Department of Urology, and Chief of Robotics and Minimally Invasive Surgery at The Mount Sinai Medical Center, Dr. David Samadi remains a steadfast proponent of the annual PSA test and the life-saving opportunities it provides for early prostate cancer treatment. "Despite the increased length of the PLCO study, I don't believe it accurately reflects the progress we have made in our fight against prostate cancer," he said.  

Dr. Samadi added, "The PSA test is effective and necessary in diagnosing prostate cancer. It might not be a perfect test but it's our only test, and there is evidence showing that it can reduce prostate cancer mortality. But the reality is that there's no straight line between detection and cure. Detection of a disease does not prevent its malicious impact on the body. Treatment is everything."

The PLCO study only focused on morbidity in relation to prostate cancer screening and diagnosis; it did not address the courses of treatment elected by those patients who received a positive diagnosis. Dr. Samadi clarified, "Diagnosis affords the opportunity for treatment. Prostate cancer can be a slow disease, but in its aggressive form it can spread very quickly without warning. PSA testing allows us to diagnose prostate cancer more readily in its initial stages; this is when a cure is possible with proper treatment."  

A large part of the controversy over the PSA test stems from the fact that some prostate cancer tumors develop at such a slow rate that men are more likely to die of alternate medical issues or age. However, other forms of prostate cancer tumors develop very rapidly without symptoms or indication of spread. Currently, testing limitations prevent experts from establishing tumor aggression at the point of diagnosis, leaving many men with the difficult decision of how and when to treat their prostate cancer.

That reality, coupled with the potential negative side effects of prostate cancer treatment, fuels concerns about over-testing and over-treatment of the disease. Urinary control issues and erectile dysfunction are potential and difficult issues men must consider. "Not all positive diagnoses need immediate, aggressive treatment. But for those who opt for definitive treatment, it's the expertise of a specialist, particularly in the case of robotic prostatectomy surgery, that can have significant impact on the success of the treatment and a man's quality of life after recovery," Dr. Samadi said.  

Dr. Samadi spoke out in 2011 about the dangers of the government task force's blanket recommendation against the PSA, the only prostate cancer screening tool available. "The risk that insurance companies could heed this shortsighted recommendation and cease benefits related to cancer prevention is unconscionable," he cautioned.

The PLCO data did give some indication that younger, healthier men could benefit from annual PSA screening, or at least a baseline screen at a younger age. Researchers also acknowledge men who are considered high risk, those with a family history or of African American descent, should consider early and regular testing.

"We can't lose sight of the lives that are saved through early detection and early treatment," reminded Dr. Samadi, "Without the PSA, a great number of men would be diagnosed with aggressive prostate cancer beyond the reach of effective treatment. That's a study we don't want to see."

Back to Press Releases


Bookmark Using:
Facebook Twitter LinkedIn Email Yahoo

Share on Facebook

Call to Make an Appointment With Dr. David Samadi:

1-212-365-5000

Click the contact link to learn how Dr. Samadi can help treat your prostate cancer and give you back your quality of life.

* The benefits of robotic surgery cannot be guaranteed as surgery is both patient and procedure specific. Previous surgical results do not guarantee future outcomes.




Testimonials
I.Z. Israel

לפני שבועיים עברתי אצלך את הניתוח בניו-יורק, ואני כבר בארץ. אני מרגיש מצוין, כבר עובד כרגיל ומצפה לעתיד טוב. עלי לציין את היחס המצוין שלך ושל הצוות סביבך הן במרפאה והן בבית החולים.

more..
Michael O

You are a rare individual…..I have traveled the world and have met thousands of people and am blessed to have many great friends and family from all walks of life, intellect, spirituality, leadership qualities and genuine nice and caring people.

more..
Louis S., USA

The operation went like clockwork and was successful. My stay at Mt. Sinai for a little over 24 hours went just as Dr. Samadi had explained at our first consultation .There were no surprises or unexpected incidents. The staff at Mt. Sinai were great. My post operative recovery is progressing well...

more..
Judith D., USA

We liked your answer very much. No one touches my patients but me. At that moment, we knew we had found our surgeon. We have never regretted that decision for a single moment. You and your staff have a level of knowledge, experience and professionalism that is unparalleled.

more..